Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.
Clinical trial NCT02235987 · COMPLETED
Trial details
- NCT number
- NCT02235987
- Sponsor
- Aspireo Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2012-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.